Purified anti-human CD309 VEGFR2 Antibody anti-CD309 - 7D4-6,BioLegend,359902

Host

Mouse

Reactivity

Human

Application

FC -Quality testedICC -Verified

Platform ID

BAB946892384

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-human CD309 VEGFR2 Antibody anti-CD309 - 7D4-6
Cat. No.359902
HostMouse
RRIDAB_2562485 (BioLegend Cat. No. 359902)
IsotypeMouse IgG1, κ
ReactivityHuman
ApplicationFC -Quality testedICC -Verified
ClonalityMonoclonal
Clone Number7D4-6
Concentration0.5 mg/ml
TargetCD309
ImmunogenHuman KDR recombinant protein
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

CD309, also known as VEGF-R2, KDR, and Flk-1 (mouse), is a type I transmembrane glycoprotein. It is a member of the CSF-1/PDGF receptor family of type III tyrosine kinase receptors. Human VEGF-R2 is mainly expressed by endothelial cells, embryonic tissues, and megakaryocytes. It plays an important role in the regulation of angiogenesis, vasculogenesis, and vascular permeability. The ligands of VEGF-R2 include VEGF-A, VEGF-C, and VEGF-D splice isoforms. Activation of VEGF-R2 with its ligands results in the receptor dimerization and autophosphorylation, stimulating endothelial cell proliferation and migration.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.